声门型喉癌的治疗  

Treatment of Carcinoma in Situs of the Glottis

作　　者：樊大庆[1] 

机构地区：[1]湖北省肿瘤医院头颈外科,湖北武汉430079

出　　处：《河南肿瘤学杂志》2003年第5期359-359,361,共2页Henan Journal of Oncology

摘　　要：目的　分析声门型喉癌在不同治疗方式下的预后及其影响预后的因素。方法　 2 12例声门型喉癌分为三组 ,即手术组 ,放疗组和手术加放疗组 ,所有病例又按是否侵犯前联合分为两组。结果　三组的五年生存率分别为 76% ,80 %和 73 %。按是否侵犯前联合分组的分别是 65 %和 88%。结论　无论采用何种方法治疗 ,声门型喉癌都有较好的预后 ,而是否侵犯前联合则是影响预后的关键。Objective To evaluate the results of different treatment modalities for carcinoma in situs of the glottis, and to analyze prognostic factors for outcome.Methods Sixty-two patients were treated with surgery, 140 with radiotherapy, and 10 with surgery and radiotherapy. Eighty-eight patients of them had anterior commissure involvement.Results The 5-year survival rate was 76% of the surgery group, 80% of radiotherapy group, and 73% of complex treatment group. The rates were 65% of anterior commissure involvement group, and 88% of without anterior commissure involvement.Conclusions All the sorts of treatment provided excellent survival rate. Anterior commissure involvement was associated with poorer survival rate.

关 键 词：声门型喉癌 手术治疗 放疗 生存率 前联合 

分 类 号：R739.65[医药卫生—肿瘤]